Medical Management of Psychotropic Side Effects

• Κύριος συγγραφέας: Annamalai, Aniyizhai (Συγγραφέας)
• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2017.
• Θέματα: Medicine.; General practice (Medicine).; Internal medicine.; Psychopharmacology.; Medicine & Public Health.; General Practice / Family Medicine.; Internal Medicine.

 This book is a practical guide for psychiatrists to use when treating patients for medical issues. Over the past 10-20 years, the number of medications prescribed for psychiatric illnesses has steadily increased, and psychiatric practitioners are frequently called upon to manage medical issues and side effects that result from psychotropic treatment. Covering a wide range of conditions from thyroid disorders to cardiac disease, this book is a helpful resource for understanding common adverse medical effects that occur when psychotropic drugs are administered. Presented in a practical format, each chapter discusses management of a particular medical problem or side effect and then provides a summary and flowchart of the major points highlighted in that chapter. Each chapter contains an overview of key medications causing a particular side effect. The book also includes special topics such as psychotropic prescribing in medical illness and tips on electrocardiographic interpretation. This easy-to-reference book aims to bridge the gap between medicine and psychiatry by elaborating on medical conditions seen in routine outpatient psychiatric practice. It serves as an invaluable tool for mental health providers, nurses, health educators, and pharmacologists alike. 

 Section I -- Chapter1 Psychotropic prescribing in medically ill patients. -Section II – Metabolic syndrome -- Chapter 2 Obesity -- Chapter 3 Diabetes mellitus and acute hyperglycemia -- Chapter 4 Hypertension and acute hypertensive crisis -- Chapter 5 Hyperlipidemia -- Section III – Cardiovascular system -- Chapter 6 Orthostatic hypotension -- Chapter 7 Tachycardia and myocarditis -- Chapter 8 QTc prolongation -- Chapter 9 Non-QT conduction abnormalities -- Chapter 10 Peripheral edema -- 11 Appendix - miscellaneous electrocardiographic abnormalities -- Section IV – Endocrine system -- Chapter 12 Hyperprolactinemia -- Chapter 13 Thyroid disorders -- Chapter 14 Hypercalcemia -- Section V – Kidney and electrolytes -- Chapter 15 Diabetes insipidus -- Chapter16 Hyponatremia -- Chapter 17 Chronic kidney disease -- Section VI – Genitourinary system -- Chapter 18 Sexual dysfunction -- Chapter 19 Urinary incontinence and retention -- Section VII – Oral and gastrointestinal system -- Chapter 20 Hepatitis -- Chapter 21 Pancreatitis -- 22 Constipation -- 23 Sialorrhea -- 24 Bruxism -- Section VIII – Hematologic system -- 25 Introduction to blood cell disorders -- Chapter 26 Leukopenia -- Chapter 27 Platelet function disorders -- Chapter 28 Thrombocytopenia -- Chapter 29 Anemia -- Chapter 30 Pancytopenia -- Chapter 31 Leukocytosis -- Chapter 32 Eosinophilia -- Section IX – Dermatology -- Chapter 33  Drug-induced cutaneous reactions -- Section X – Neurologic system -- Section X A – Movement disorders -- Chapter 34 Introduction to movement disorders -- Chapter 35 Tremor -- Chapter36 Extrapyramidal symptoms I (Parkinsonism) -- Chapter 37  Extrapyramidal symptoms II (Dystonia, akathisia, tardive dyskinesia) -- Chapter 38 Tics -- Section X B – Systemic syndromes -- Chapter 39 Myoclonus and serotonin syndrome -- Chapter 40 Creatine kinase elevation and neuroleptic malignant syndrome -- Section X C – Other neurologic conditions -- Chapter 41 Seizures -- Chapter 42 Altered mental status -- Section XI – Others -- Chapter 43 Xerostomia -- Chapter 44 Sedation -- Chapter 45 Priapism -- Chapter 46 Polycystic ovarian syndrome -- Chapter 47 Osteoporosis -- Chapter 48 Drug-induced lupus -- Chapter 49 Cataracts -- Chapter 50 Nephrolithiasis.  .